Issue: Volume X No. 1 - January 20, 2003

Why There’s “Bad Blood” Against National Labs

I AM FREQUENTLY ASKED BY WALL STREET TYPES why there seems to be latent, even deep-seated animosity between a large number of local laboratories and both of the two blood brothers. They wonder why, for example, hospital laboratories aren’t more interested in doing collaborative ventures with either of the two national laboratories. Of course, the …

Why There’s “Bad Blood” Against National Labs Read More »

New Trends in 2003 Affect Clinical Lab Services

CEO SUMMARY: Here’s our current list of macro trends that affect clinical laboratories, updated from the last list in January 2000. One bold prediction is that Medicare, as we know it, is on the verge of a major meltdown. Employers and consumers are also new forces to be reckoned with by healthcare providers. Factors other …

New Trends in 2003 Affect Clinical Lab Services Read More »

New Market Channel For Esoteric Testing

CEO SUMMARY: It’s a new marketing model for specialty esoteric tests that presents both clinical and financial challenges to hospital and health system laboratories. Niche labs offering esoteric tests are sending sales reps directly to physicians and bypassing pathologists and lab directors at local hospital laboratories. These tests come bundled in high-priced panels and often …

New Market Channel For Esoteric Testing Read More »

“January 20, 2003 Intelligence: Late Breaking Lab News”

December proved to be an eventful month for many companies in the lab industry. Here’s some key items of interest, many to be followed in more detail in coming issues of THE DARK REPORT: •AmeriPath, Inc. is to be sold to Welsh, Carson, Anderson & Stowe, a private equity firm in New York. Welsh Carson …

“January 20, 2003 Intelligence: Late Breaking Lab News” Read More »